ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)

South Korea · Delayed Price · Currency is KRW

2,925.00

-15.00 (-0.51%)

At close: Oct 23, 2026

ImmuneOncia Therapeutics Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	-	111.21	654.54	110	7,733	35.95
Revenue Growth	-	-83.01%	495.04%	-98.58%	21413.29%	1337.90%
Gross Profit	-14.38	98.26	643.42	92.91	7,716	28.15
Operating Income	-30,186	-28,005	-12,599	-11,797	-15,073	-11,896
Net Income	-29,306	-27,363	-5,687	8,864	-3,492	-60,490
Earnings Per Share	-385.23	-389.65	-101.00	169.00	-67.00	-1302.00
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	93,170	23,438	11,326	25,957	26,730	42,320
Total Debt	41.65	69.53	95.06	136.94	122.97	314.63
Net Cash (Debt)	93,128	23,368	11,231	25,820	26,607	42,005
Net Cash Growth	141.73%	108.06%	-56.50%	-2.96%	-36.66%	103.58%
Net Cash Per Share	1224.17	332.76	199.46	492.28	510.53	904.13

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-26,301	-22,775	-14,670	-8,337	-15,301	-1,976
Capital Expenditures	-375.15	-329.97	-86.87	-428.43	-36.21	-101.34
Free Cash Flow	-26,676	-23,105	-14,757	-8,766	-15,337	-2,078
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	-	88.36%	98.30%	84.47%	99.77%	78.31%
Operating Margin	-	-25182.04%	-1924.80%	-10724.51%	-194.91%	-33093.66%
Pretax Margin	-	-24605.12%	-868.86%	8058.20%	-45.15%	-168272.99%
Profit Margin	-	-24605.12%	-868.86%	8058.20%	-45.15%	-168272.99%
FCF Margin	-	-20776.54%	-2254.59%	-7968.93%	-198.32%	-5779.96%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	-	8683.03	-	-	-	-